Mast Therapeutics, Inc. (MSTX)

[lux1]

they are talking about commercialisation at the national conference of Association of Bioscience Financial Officers (ABFO)

Brandi Roberts speeches
Yesterday 2:00 pm
MODERATOR - Brandi Roberts, Chief Financial Officer, Mast Therapeutics, Inc.
This moderated roundtable discussion will focus on issues commonly faced by mature life science companies that have been public for three years or more and have or are about to launch commercial products. Topics will include product launch challenges, considerations and best practices, international expansion issues, distribution models, FCPA, tax planning strategies and ERP-related issues, amongst others.

Today 10:15 am and 12:50 am
C. "Best Practices for Managing Global Clinical Finance"
Are your corporate finance interests and clinical trial goals aligned? This panel of experts from Ernst & Young, Mast Therapeutics, Mirati Therapeutics, and Medidata Solutions will discuss best practices for managing global clinical finance across your R&D portfolio. They’ll address common pitfalls when it comes to managing the site payment process on global trials, managing accruals, forecasting and transparency reporting, outsourcing clinical finance operations, and selecting technology.

here the Agenda
http://www.abfointernational.org/2016/2016Agenda.html